PMVP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
PMV Pharmaceuticals Inc (PMVP) is not a strong buy for a beginner investor with a long-term strategy at this time. The stock lacks significant positive catalysts, has weak financial performance, and shows a bearish trend in price projections. While hedge funds are buying, this alone does not outweigh the negative factors, especially given the company's declining financials and reduced price target by analysts.
The stock's MACD is positive but contracting, RSI is neutral at 51.44, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock's recent trend suggests a 40% chance of declining by -3.26% in the next day, -5.69% in the next week, and -5% in the next month. Key support and resistance levels are Pivot: 1.361, R1: 1.452, S1: 1.269, R2: 1.509, S2: 1.213.
Hedge funds are significantly increasing their buying activity, with a 2450.33% increase in the last quarter.
Analysts have significantly reduced the price target from $16 to $4, and the company's financials show declining net income (-21.58% YoY) and EPS (-22.73% YoY). No recent news or congress trading data is available to suggest a positive catalyst.
In 2025/Q4, the company's revenue remained at $0 (0.00% YoY growth), net income dropped to -$18,037,000 (-21.58% YoY), and EPS fell to -0.34 (-22.73% YoY). Gross margin remained at 0%.
Evercore ISI recently lowered the price target from $16 to $4 while maintaining an Outperform rating. This indicates a cautious outlook on the stock's future performance.
